Efficacy and Safety of a Multiple-Action Tear Substitute (TriMix) in Dry Eye Disease
Status:
COMPLETED
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to assess the efficacy and safety of TriMix tear substitute in patients with dry eye disease. For this purpose, a randomized, double-blind clinical trial has been designed, using an Hyaluronic acid-based tear substitute as a control.